P2B001 (low dose combination of extended-release pramipexole and rasagiline) versus titrated extended-release pramipexole in the management of early Parkinson's disease: Exploratory findings from a randomized, controlled trial

被引：0
|
作者：
Elmer, Lawrence [1 ]
Litman, Pninit [2 ]
Friedman, Hadas [2 ]
Fitzer-Attas, Cheryl [2 ]
Oren, Sheila [2 ]
机构：
[1] Univ Toledo, Coll Med & Life Sci, Dept Neurol, Toledo, OH USA
[2] Pharma Two B, Rehovot, Israel
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203489
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S32.010
引用
收藏
页数：4
相关论文
共 41 条
  • [31] Once-daily pramipexole extended-release (ER) demonstrated non-inferiority compared to immediate release (IR) tid dosing in early Parkinson's disease
    Poewe, W.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Rascol, O.
    Schapira, A.
    Haaksma, M.
    Juhel, N.
    Salin, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S131 - S131
  • [32] P2B001 significantly reduced risk of daytime sleepiness: results from a randomized controlled phase 3 trial with active pramipexole arm in early Parkinson's disease (PD)
    Kreitzman, David
    Litman, Pninit
    Friedman, Hadas
    Oren, Sheila
    Fitzer-Attas, Cheryl
    NEUROLOGY, 2023, 100 (17)
  • [33] Randomized, Placebo-Controlled Trial of ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 3)
    Oertel, Wolfgang
    Eggert, Karla
    Pahwa, Rajesh
    Tanner, Caroline M.
    Hauser, Robert A.
    Trenkwalder, Claudia
    Ehret, Reinhard
    Azulay, Jean Philippe
    Isaacson, Stuart
    Felt, Larissa
    Stempien, Mary Jean
    MOVEMENT DISORDERS, 2017, 32 (12) : 1701 - 1709
  • [34] How to Dose Extended-release Carbidopa-levodopa Capsules (IPX203) In Parkinson's Disease Patients: Experience from the Phase 3 Clinical Trial
    Hauser, R.
    Banisadr, G.
    Fisher, S.
    Visser, H.
    D'Souza, R.
    MOVEMENT DISORDERS, 2023, 38 : S27 - S28
  • [35] HOW TO DOSE EXTENDED-RELEASE CARBIDOPA-LEVODOPA CAPSULES (IPX203) IN PARKINSON'S DISEASE PATIENTS: EXPERIENCE FROM THE PHASE 3 CLINICAL TRIAL
    Hauser, R. A.
    Banisadr, G.
    Fisher, S.
    Visser, H.
    D'Souza, R.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [36] De novo low-dose sirolimus versus mycophenolate mofetil in combination with extended-release tacrolimus in kidney transplant recipients: a multicentre, open-label, randomized, controlled, non-inferiority trial
    Huh, Kyu Ha
    Lee, Jae Geun
    Ha, Jongwon
    Oh, Chang-Kwon
    Ju, Man Ki
    Kim, Chan-Duck
    Cho, Hong Rae
    Jung, Cheol Woong
    Lim, Beom Jin
    Kim, Yu Seun
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (08) : 1415 - 1424
  • [37] Patient-Reported Outcomes From the Randomized Phase 2b/3 PRISM Trial Evaluating Oral Nalbuphine Extended-Release Versus Placebo in Patients With Prurigo Nodularis
    Staender, Sonja
    Weisshaar, Elke
    Parish, Jennifer L.
    Szepietowski, Jacek C.
    Reich, Adam
    Korman, Neil J.
    Bortey, Enoch
    Sciascia, Thomas R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB73 - AB73
  • [38] Double-Blind, Placebo-Controlled Fixed-Dose Trial of IPX066, a Novel Carbidopa-Levodopa (CD-LD) Extended-Release Formulation, in Early Parkinson's Disease (APEX-PD Trial)
    Pahwa, Rajesh
    Hauser, Robert
    Jankovic, Joseph
    Nausieda, Paul
    Ellenbogen, Aaron
    Hsu, Ann
    Gupta, Sunell
    NEUROLOGY, 2011, 77 (02) : 199 - 199
  • [39] Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: A randomized, single-blind, 30-day trial
    Serebruany, Victor L.
    Malinin, Alex I.
    Pokov, Alex N.
    Hanley, Daniel F.
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 249 - 259
  • [40] Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: The prevention regimen for effectively avoiding second strokes trial (PRoFESS)
    Sacco, R.
    Diener, H. C.
    Yusuf, S.
    CEREBROVASCULAR DISEASES, 2008, 25 (1-2) : 192 - 192
12345